Table: Garna Biosciences - 6-MTH group results

Carna Biosciences

05/08/2022 07:30

Aug 5 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to   
                Jun 30, 2022        Jun 30, 2021       Dec 31, 2022  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            839 mln             430 mln             1.19      
                 (+95.2 pct)         (-25.8 pct)       (-41.2 pct)   
  Operating     loss 312 mln        loss 777 mln        loss 1.67    
  Recurring     loss 306 mln        loss 774 mln        loss 1.69    
  Net           loss 359 mln        loss 776 mln        loss 1.74    
  EPS          loss 26.53 yen      loss 62.56 yen    loss 128.46 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T